top of page

O U R   P U B L I C A T I O N S

I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add your own content and make changes to the font. Feel free to drag and drop me anywhere you like on your page. I’m a great place for you to tell a story and let your users know a little more about you.


This is a great space to write long text about your company and your services. You can use this space to go into a little more detail about your company. Talk about your team and what services you provide. Tell your visitors the story of how you came up with the idea for your business and what makes you different from your competitors. Make your company stand out and show your visitors who you are.

P U B L I S H E D   R E S E A R C H

1.

Un-“ESCRT”-ed budding.

Yondola M, Carter C.

Virus. 2011 Jan;3(1):26-31. doi: 10.3390/v3010026.

PMID: 21666754  PMCID: PMC3110670  DOI: 10.3390/v3010026

 

2.

Modulation of an ectodomain motif in the influenza A virus neuraminidase alters tetherin sensitivity and results in virus attenuation in vivo.

Leyva-Grado VH, Hai R, Fernandes F, Belicha-Villanueva A, Carter C, Yondola MA.

Journal of Molecular Biology. 2014 Mar 20;426(6):1308-21. Epub 2013 Dec 29.

PMID: 24380762 PMCID: PMC3963499​  DOI: 10.1016/j.jmb.2013.12.023

 

3.

Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.

Krammer F, Hai R, Yondola M, Tan GS, Leyva-Grado VH, Ryder AB, Miller MS, Rose JK, Palese P, García-Sastre A, Albrecht RA.

Journal of Virology. 2014 Mar;88(6):3432-42. doi: 10.1128/JVI.03004-13. Epub 2014 Jan 8.

PMID: 24403585  PMCID: PMC3957929​  DOI: 10.1128/JVI.03004-13

 

4.

Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.

Leyva-Grado VH, Tan GS, Leon PE, Yondola M, Palese P.

Antimicrobial Agents and Chemotherapy. 2015 Jul;59(7):4162-72. doi: 10.1128/AAC.00290-15. Epub 2015 May 4.

PMID: 25941218  PMCID: PMC4468714​  DOI: 10.1128/AAC.00290-15

 

5.

Adenovirus E4-ORF3-dependent relocalization of TIF1α and TIF1γ relies on access to the Coiled-Coil motif.

Vink EI, Yondola MA, Wu K, Hearing P.

Virology. 2012 Jan 20;422(2):317-25. doi: 10.1016/j.virol.2011.10.033. Epub 2011 Nov 27.

PMID: 22123502  PMCID: PMC3249475​  DOI: 10.1016/j.virol.2011.10.033

 

6.

Budding capability of the influenza virus neuraminidase can be modulated by tetherin.

Yondola MA, Fernandes F, Belicha-Villanueva A, Uccelini M, Gao Q, Carter C, Palese P.

Journal of Virology. 2011 Mar;85(6):2480-91. doi: 10.1128/JVI.02188-10. Epub 2011 Jan 5.

PMID: 21209114  PMCID: PMC3067929​  DOI: 10.1128/JVI.02188-10

 

7.

Influenza virus vaccine based on the conserved hemagglutinin stalk domain.

Steel J, Lowen AC, Wang TT, Yondola M, Gao Q, Haye K, García-Sastre A, Palese P.

mBio. American Society for Microbiology. 2010 May 18;1(1):e00018-10. doi: 10.1128/mBio.00018-10.

PMID: 20689752  PMCID: PMC2912658​  DOI: 10.1128/mBio.00018-10

 

8.

The adenovirus E4 ORF3 protein binds and reorganizes the TRIM family member transcriptional intermediary factor 1 alpha.

Yondola MA, Hearing P.

Journal of Virology. 2007 Apr;81(8):4264-71. doi: 10.1128/JVI.02629-06. Epub 2007 Feb 7.

PMID: 17287283  PMCID: PMC1866117​  DOI: 10.1128/JVI.02629-06

 

9.

Formulation of the prefusion RSV F protein with a Th1/Th2-balanced adjuvant provides complete protection without Th2-skewed immunity in RSV-experienced young mice.

Kosanovich JL, Eichinger KM, Lipp MA, Yondola MA, Perkins TN, Empey KM.

Vaccine. 2020 Sep 22;38(41):6357-6362. doi: 10.1016/j.vaccine.2020.08.023. Epub 2020 Aug 20.

PMID: 32829976 PMCID: PMC7540734 (2021-09-22)​  DOI: 10.1016/j.vaccine.2020.08.023

 

10.

Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection.

Eichinger KM, Kosanovich JL, Gidwani SV, Zomback A, Lipp MA, Perkins TN, Oury TD, Petrovsky N, Marshall CP, Yondola MA, Empey KM.

Frontiers in Immunology. 2020 Jul 29;11:1673. doi: 10.3389/fimmu.2020.01673. eCollection 2020.

PMID: 32849580  PMCID: PMC7403488​  DOI: 10.3389/fimmu.2020.01673

 

11.

Biophysical and functional analyses suggest that adenovirus E4-ORF3 protein requires higher-order multimerization to function against promyelocytic leukemia protein nuclear bodies.

Patsalo V, Yondola MA, Luan B, Shoshani I, Kisker C, Green DF, Raleigh DP, Hearing P.

Journal of Biological Chemistry. 2012 Jun 29;287(27):22573-83. doi: 10.1074/jbc.M112.344234. Epub 2012 May 9.

PMID: 22573317 PMCID: PMC3391147​  DOI: 10.1074/jbc.M112.344234

​

12.    
Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection.
Eichinger KM, Kosanovich JL, Gidwani SV, Zomback A, Lipp MA, Perkins TN, Oury TD, Petrovsky N, Marshall CP, Yondola MA, Empey KM.
Frontiers in Immunology. 2020 Jul 29;11:1673. doi: 10.3389/fimmu.2020.01673. eCollection 2020.
PMID: 32849580 PMCID: PMC7403488  DOI: 10.3389/fimmu.2020.01673

​

13

Calder Biosciences: Engineering Solutions for Improved Vaccines

Scientia. 2019 Feb 6. Biology, Health and Medicine

​

​

bottom of page